Trial intelligence / Profile preview

Treprostinil for PH in IPF

NCT00705133Phase 2Completed

Start
Jul 2008
Primary completion
Jan 2011
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of treprostinil in pulmonary arterial hypertension (PAH). Started Jul 2008; status: completed.

02

Drugs

treprostinil
03

Conditions

pulmonary arterial hypertension (PAH)

Beyond the preview

Go deeper on NCT00705133.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00705133.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call